Latest Breaking News On - லூபின் வரையறுக்கப்பட்டவை - Page 8 : comparemela.com
Global Generic Drugs Market Forecast & Opportunities, 2026: Increasing Count of Drug Patent Expirations is Expected to Bolster Market Growth
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Generic Drugs Market Forecast & Opportunities, 2026: Increasing Count of Drug Patent Expirations is Expected to Bolster Market Growth
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global generic drugs market reached a value of US$ 386 Billion in 2020. A generic drug is a medicine that contains the same active ingredient and has an equivalent therapeutic effect as the branded drug. It is also identical in terms of safety, quality, dosage, strength, route of administration, intended use, effect, form, quality and side effects. These medications can be produced only after the patent expiration of the brand-name drug. As compared to branded drugs, the production of generics costs much less as it does not require the repetition of clinical (human) and animal studies to demonstrate the effectiveness and safety of the medicine. Due to a reduction in the upfront cost of research, generics are typically sold at a substantially lower price in the market.
(0)
NEW YORK, April 8, 2021 /PRNewswire/ The World Health Organization (WHO) has designated October 10
th as World Mental Health Day in order to raise awareness about such issues and lessen people s hesitation in seeking treatment. As a result of such initiatives, the global
anxiety and depression treatment market value is predicted to increase from $17,770.9 million in 2020 to $24,467.7 million by 2030, at a 3.3% CAGR between 2021 and 2030, according to the market research report published by P&S Intelligence.
Similarly, a program, named Better Outcomes in Mental Health Care (BOiMHC), and an organization, called Mental Health Association, have been formed to help the cause in Australia. Another such organization aiding the anxiety and depression treatment market growth with its support to patients and educational courses is the National Alliance on Mental Illness (NAMI), which was founded in the U.S. in 1979.
Lupin Ltd is quoting at Rs 1036.75, up 0.76% on the day as on 12:49 IST on the NSE. The stock is up 48.1% in last one year as compared to a 66.74% spurt in NIFTY and a 53.33% spurt in the Nifty Pharma.
Lupin Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1036.75, up 0.76% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.15% on the day, quoting at 14659.7. The Sensex is at 49158.46, down 0%. Lupin Ltd has dropped around 1.3% in last one month.
Meanwhile, Nifty Pharma index of which Lupin Ltd is a constituent, has dropped around 1.78% in last one month and is currently quoting at 12331.5, up 1.03% on the day. The volume in the stock stood at 8.81 lakh shares today, compared to the daily average of 16.58 lakh shares in last one month.
vimarsana © 2020. All Rights Reserved.